Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

AMCN, ORFG, PWRM - Thursday Morning Stock Highlights! from CRWEfinance.com

crwefinancelogo2

signup3m

___

AirMedia Group Inc. (Nasdaq:AMCN), a leading operator of out-of-home advertising platforms in China targeting mid-to-high-end consumers, today announced that it recently renewed its concession rights contract with China Eastern Airlines to operate digital TV screens on its airplanes on an exclusive basis for ten years until December 31, 2020.

"China Eastern Airlines is one of the top three airlines in China. Our successful renewal with China Eastern Airlines further secures our concession rights with major airlines for the long term. Following our recent renewals of concession rights contracts with Terminal 3 of the Beijing airport and China Southern Airlines, each for five years, we notice that airports and airlines now become willing to commit to longer-term contracts with their trusted business partners. As a leading air travel advertising platform operator, AirMedia will benefit from this development," remarked Herman Guo, chairman and chief executive officer of AirMedia.

AirMedia Group Inc., through its subsidiaries, operates digital media network in China for air travel advertising. It operates digital frames and digital TV screens that display advertisements in airports and airplanes. The company also displays non-advertising content, such as weather, sports, and comedy clips; and documentaries and hidden camera type reality shows from other third-party content providers in its digital TV screen programs. In addition, it displays advertisements on interior or exterior walls of gate bridges, including billboard and painted advertisements, as well as operates light boxes and billboards at airports. Further, the company holds concession rights to operate various traditional advertising media, including billboards, light boxes, and other media platforms out of the air travel sector. As of April 30, 2010, it operated digital frames in 33 airports in China; digital TV screens in 37 airports; 525 light boxes and billboards in 3 airports; and 114 billboard advertisements and 46 painted advertisements on the gate bridges located in 7 airports. The company was founded in 2005 and is headquartered in Beijing, China.

******

orfg_logo203x87  Orofino Gold Corp. (ORFG.PK)

Orofino Gold Corp. is a China based gold producer with one producing gold mine in Colombia and an option on a strong portfolio of small producers and development/exploration assets in Colombia.

ORFG was founded as a private company in 2009 by former executives and management with over 50 years of combined mining exploration, finance and development experience.

ORFG's corporate objective is to continue to build shareholder value through the exploration and development of existing projects and additional accretive acquisitions, capitalizing on the extensive experience and relationships that management has developed over the past 25 years.

http://pennyomega.com/img/orfg_highlight3.jpg

La Azul - Senderos de Oro Area

La Azul is one producing artesanal mine in the Senderos de Oro area controlled by ORFG, it is a mixed sequence of predominantly volcanic rocks with the vien systems comprised of high grade chalcopyrite, galena and sphalerite with pyrite in quartz viens.

It has been interpreted (by Shaw 1993) that the metallogenic zonation around the La Azul workings evokes a very viable "hidden porphyry" exploration model. This interpretation and the prospectivity of the area have been confirmed by the Orofino "qualified person" as per the 43-101 rules.

ORFG will move ahead aggressively in the last quarter of 2010 to persue the current interpretations, work programs and drilling will begin soon.

To learn about ORFG visit:  http://www.orofinogold.com

******

Power3 Medical Products, Inc. (OTC:PWRM)

Power3 Medical Products, Inc., a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, recently announced PWRM management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer's and Parkinson's, to name a few.

In addition, PWRM is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by PWRM several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for PWRM's depressed stock price and have distracted the company from its mission, PWRM plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, PWRM will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. PWRM intends to appeal this decision.

"We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now," stated Ira L. Goldknopf, President and Chief Scientific Officer of PWRM. "We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger."

Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. PWRM plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into PWRM, with PWRM remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.

http://pennyomega.com/img/pwrm_highlight2.jpg

To learn more about PWRM visit: http://www.Power3Medical.com

___

********************************************************************

http://crwefinance.com/img/crwefinance_new_buscard2.jpg

Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.  Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).  Crown Equity Holdings Inc. (OTCPK:CRWE) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.